STACIE JOHNSON: Open Payments
NPI 1205212677 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,495 in 67 payments from 21 companies in 2025. Trend: 2023 $998 · 2024 $2,673 · 2025 $1,495
Food & beverage: $1,495
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $430 |
| Collegium Pharmaceutical, Inc. | 11 | $149 |
| Medtronic, Inc. | 1 | $128 |
| TerSera Therapeutics LLC | 3 | $97 |
| PROTEGA PHARMACEUTIALS INC | 5 | $95 |
| Lundbeck LLC | 3 | $79 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $66 |
| SI-BONE, INC. | 3 | $64 |
| Boston Scientific Corporation | 2 | $49 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
Products named: QULIPTA, BOTOX, INTELLIS ADAPTIVESTIM, Belbuca, Prialt, ROXYBOND, VYEPTI, UBRELVY.
Industry payments across NE — which companies pay providers there.
